DIN 02536552 — COLUMVI 2.5 MG
COLUMVI is a solution of Glofitamab marketed by HOFFMANN-LA ROCHE LIMITED. The full Glofitamab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02536552
- Brand name
- COLUMVI
- Active ingredient
- Glofitamab
- Strength
- 2.5 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- CD20xCD3 bispecific T-cell engaging monoclonal antibody (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Glofitamab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02536560 | COLUMVI | 10 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |